Summary
Concentrations of human C-peptide, IRI (immunoreactive insulin) and glucose were determined during oral glucose tolerance test (1.75 g glucose/kg ideal body weight) in 14 normal persons (N), 9 maturity-onset diabetics (DI) and 10 insulin-requiring diabetics (DII) never treated with insulin and in 3 formerly insulin treated diabetics. The mean fasting levels of C-peptide and IRI in the first three groups were: N: 0.37 ± 0.02 nM and 0.048 ± 0.009 nM, DI: 0.86 ± 0.17 nM and 0.11 ± 0.029 nM, DII: 0.37 ± 0.04 nM and 0.063 ± 0.009 nM. One hour after oral glucose ingestion, the respective values increased to: N: 2.53 ± 0.20 nM and 0.52 ± 0.077 nM, DI: 2.49 ± 0.31 nM and 0.49 ± 0.11 nM, DII: 0.49 ± 0.05 nM and 0.11 ± 0.014 nM. Although secreted from the pancreas in equimolar concentrations, the molar ratio of C-peptide to insulin in peripheral blood was about 7 in the fasting state, falling to about 5 in the glucose stimulated condition. Maturity-onset diabetics had higher fasting levels of C-peptide than normal subjects, in agreement with the IRI levels. Three patients previously treated with insulin and having insulin antibodies showed C-peptide responses significantly below the normal range. In one of these patients, the test was repeated 9 months later when the insulin antibodies had disappeared, and the C-peptide response observed at that time was much higher. It is suggested that insulin antibodies cause an impaired IRI — and consequently C-peptide response — by constantly removing insulin from the granules in the B-cell. In normal humans the peripheral C-peptide responses to the oral glucose load showed less relative variation than do the insulin responses. Therefore, a radioimmunoassay for C-peptide in addition to the assay for insulin will provide supplementary information on insulin secretion.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Block, M. B., Mako, M. E., Steiner, D. F.: Rubenstein, A. H.: Circulating C-peptide immunoreactivity. Studies in normals and diabetic patients. Diabetes 21, 1013–1026 (1972)
Block, M. B., Mako, M. E., Steiner, D. F., Rubenstein, A. H.: Diabetic ketoacidosis: Evidence for C-peptide and proinsulin secretion following recovery. J. clin. Endocr. 35, 402–406 (1972)
Block, M. B., Rosenfield, R. L., Mako, M. E., Steiner, D. F., Rubenstein, A. H.: Sequential changes in beta-cell function in insulin-treated diabetic patients assessed by C-peptide immunoreactivity. New Engl. J. Med. 288, 1144–1148 (1973)
Blumenthal, D. S., Berns, A. W., Blumenthal, H. T.: Anti-insulin serum effects on islets of Langerhans of chick embryo. Arch. Path. 77, 107–112 (1964)
Gregor, W. H., Martin, J. M., Williamson, J. R., Lacy, P. E., Kipnis, D. M.: A study of the diabetic syndrome produced in rats by anti-insulin serum. Diabetes 12, 73–81 (1963)
Heding, L. G.: Radioimmunological determination of human C-peptide in serum. Accepted by Diabetologia (1975)
Heding, L. G.: Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 8, 260–266 (1972)
Heding, L. G., Munkgaard Rasmussen, S.: Determination of pancreatic and gut glucagon-like immunoreactivity (GLI) in normal and diabetic subjects. Diabetologia 8, 408–411 (1972)
Heding, L. G., Larsen, U. D., Markussen, J., Jørgensen, K. H., Hallund, O.: Radioimmunoassays for human, pork and ox C-peptides and related substances. Horm. Metab. Res. Suppl. Vol. 5, 40–44 (1974)
Katz, A. I., Rubenstein, A. H.: Metabolism of proinsulin, insulin and C-peptide in the rat. J. clin. Invest. 52, 1113–1121 (1972)
Melani, F., Rubenstein, A. H., Oyer, P. E., Steiner, D. F.: Identification of proinsulin and C-peptide in human serum by a specific immunoassay. Proc. nat. Acad. Sci. (Wash.) 67, 148–155 (1970)
Morgan, C. R., Carpenter, A. M., Lazarow, A.: Effect of insulin antibodies on pancreatic islet insulin and beta cell granule content. Anat. Rec. 153, 49–54 (1965)
Rubenstein, A. H., Block, M. B., Starr, J., Melani, F., Steiner, D. F.: Proinsulin and C-peptide in blood. Diabetes 21, Suppl. 2, 661–672 (1972)
Schlichtkrull, J.: Proinsuline et substances apparentées. Path. et Biol. 19, 885–892 (1971)
Stoll, R. W., Touber, J. L., Ensinck, J. W., Williams, R. H.: Substances immunologically related to proinsulin or connecting peptide in swine plasma. Horm. Metab. Res. 2, 153–156 (1970)
Toreson, W. E., Lee, J. C., Grodsky, G. M.: The histopathology of immune diabetes in the rabbit. Amer. J. Path. 52, 1099–1109 (1968)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Heding, L.G., Rasmussen, S.M. Human C-peptide in normal and diabetic subjects. Diabetologia 11, 201–206 (1975). https://doi.org/10.1007/BF00422322
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00422322